Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial ‑to‑mesenchymal transition through the Wnt/β‑catenin pathway.

In conclusion, HPSE appears to be a good candidate as a molecular target for the treatment of PC based on the finding of the present study. PMID: 32627022 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32627022?dopt=Abstract

Source: Oncology Reports - July 7, 2020 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research